VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 68 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 8.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,698 | -32.7% | 1,724 | 0.0% | 0.00% | – |
| Q2 2023 | $9,947 | +10.5% | 1,724 | +59.6% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 1,080 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -28.6% | 1,080 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | +16.7% | 1,080 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 1,080 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $16,000 | +33.3% | 1,080 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +50.0% | 1,080 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -33.3% | 1,080 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | 0.0% | 1,080 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -29.4% | 1,080 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $17,000 | +6.2% | 1,080 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | +433.3% | 1,080 | +260.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |